A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19

The existing pandemic viral infection caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) leads to coronavirus disease 2019 (Covid-19). SARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as an entry-point into affected cells and down-regulation of ACE2 by this virus t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostafa-Hedeab, Gomaa, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Jeandet, Philippe, Saad, Hebatallah M., Batiha, Gaber El-Saber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051499/
https://www.ncbi.nlm.nih.gov/pubmed/35486310
http://dx.doi.org/10.1007/s10787-022-00993-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051499/
https://www.ncbi.nlm.nih.gov/pubmed/35486310
http://dx.doi.org/10.1007/s10787-022-00993-1

Ejemplares similares